Full Press Release Details
Director's Interest Notice
Final Director's Interest Notice
Information or documents not available
now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
| Name of entity: Radiopharm Theranostics Limited (ASX: RAD) |
| ABN: 57 647 877 889 |
We (the entity) give ASX the
following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | Leila Alland |
| Date of last notice | 18 December 2024 |
| Date that director ceased to be director | 20 November 2025 |
Part 1 - Director's relevant
interests in securities of which the director is the registered holder
of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company,
interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in
| + See chapter 19 for defined terms. | |
| 11/3/2002 | |
| Appendix 3Z Page 1 |
Final Director's Interest Notice
Part 2 - Director's relevant
interests in securities of which the director is not the registered holder
Note: In the case of a company,
interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in
of a trust, this includes interests in the trust made available by the responsible entity of the trust
Director's interests in contracts
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| No. and class of securities to which interest relates | N/A |
| + See chapter 19 for defined terms. | |
| Appendix 3Z Page 2 | 11/3/2002 |